Cipla gets final nod from USFDA for migraine treatment nasal spray

Cipla Ltd on Thursday said it has received final approval from the US health regulator for Dihydroergotamine Mesylate nasal spray, indicated for th

from Business Line - Companies https://ift.tt/3gdgx02